Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFNα-induced depression
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (1) , 37-50
- https://doi.org/10.1016/j.gtc.2003.12.005
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis CMolecular Psychiatry, 2002
- Antidepressant reversal of interferon-α-induced anhedoniaPhysiology & Behavior, 2002
- Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic SystemJournal of Clinical Psychopharmacology, 2002
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A ReviewAmerican Journal of Psychiatry, 2000
- Therapy of hepatitis C: Interferon alfa-n1 trialsHepatology, 1997
- Side effects of high-dose interferon therapy for chronic hepatitis CJournal of Hepatology, 1996
- Suicide associated with alfa-interferon therapy for chronic viral hepatitisJournal of Hepatology, 1994
- Psychiatric complications of long-term interferon alfa therapyArchives of internal medicine (1960), 1987